MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
Acutus Medical DSO Ratio 2011-2026 | AFIB
Annual DSO Ratio Acutus Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 746 | 1.3 K | 61.2 | 93.1 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.3 K | 61.2 | 549 |
Quarterly DSO Ratio Acutus Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 166 | 188 | 240 | - | 368 | 392 | 971 | - | 72.7 | 62.4 | 81.9 | - | 74.9 | 56.5 | 58.9 | - | 62.1 | 174 | 69.8 | - | 37.1 | 16.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 971 | 16.4 | 182 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 39.27 | -1.36 % | $ 5.85 K | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
72 | $ 7.82 | 4.13 % | $ 561 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 9.4 | -2.49 % | $ 1.27 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.99 | -2.68 % | $ 149 M |  France |
 |
CONMED Corporation
CNMD
|
64.5 | $ 43.41 | -5.2 % | $ 1.35 B | USA |
 |
Electromed
ELMD
|
137 | $ 23.98 | -0.5 % | $ 203 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
40.7 | $ 29.83 | -2.68 % | $ 1.37 B | USA |
 |
Apyx Medical Corporation
APYX
|
85.8 | $ 3.17 | -3.35 % | $ 110 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
FONAR Corporation
FONR
|
237 | $ 18.5 | -0.32 % | $ 121 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
69.7 | $ 0.53 | -4.57 % | $ 54.5 M | USA |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
29.4 | - | 10.28 % | $ 55.5 M | Israel |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.8 | 6.81 % | $ 43.5 M | USA |
 |
Align Technology
ALGN
|
86.7 | $ 182.64 | -3.38 % | $ 13.7 B | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
48 | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 3.68 | -4.42 % | $ 779 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
61.2 | $ 113.61 | -0.45 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
70.4 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
67.6 | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 73.85 | -3.11 % | $ 109 B | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 1.98 | -6.6 % | $ 1.2 M | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 13.02 | -3.34 % | $ 1.95 B | USA |
 |
InMode Ltd.
INMD
|
5.36 | $ 13.6 | -0.29 % | $ 879 M | Israel |
 |
Edwards Lifesciences Corporation
EW
|
38.2 | $ 85.28 | -2.18 % | $ 49.9 B | USA |
 |
IRIDEX Corporation
IRIX
|
45.6 | $ 1.43 | 1.42 % | $ 23.1 M | USA |
 |
IRadimed Corporation
IRMD
|
56.8 | $ 104.29 | 0.53 % | $ 1.32 B | USA |